Lucid Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Lucid Diagnostics | DEFA14A: Others
Lucid Diagnostics | 8-K: Current report
Lucid Diagnostics | 8-K: Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
Lucid Diagnostics | 10-Q: Quarterly report
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Matheis Dennis
Lucid Diagnostics | 3: Initial statement of beneficial ownership of securities-Director Matheis Dennis
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer O'Neil Shaun
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Gordon Michael Adam
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer MCGRATH DENNIS M
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Aklog Lishan
Lucid Diagnostics | 8-K: Current report
Lucid Diagnostics | 8-K: Current report
Lucid Diagnostics | DEFA14A: Others
Lucid Diagnostics | ARS: Annual Report to Security Holders
Lucid Diagnostics | DEF 14A: Definitive information statements
Lucid Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Lucid Diagnostics | 10-K: Annual report
Lucid Diagnostics | 8-K: Current report
Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Lapidus Stanley
No Data